Ustar Biotechnologies (hangzhhou) Ltd.

Ustar, established in 2005, is committed to the research, development, manufacturing and sales of innovative
point-of-care molecular diagnostic technology and products. Ustar has technical platforms with completely
independent IP rights and more than 200 R&D employees, over 50% of whom hold master's degrees and above.
By far, Ustar's products have been certified or authorized by NMPA, CE, ANVISA, TGA, and HSA, and served nearly
3,000 medical institutions in over 70 countries.